Vg Life Sciences Stock Performance
| VGLS Stock | USD 0.0001 0.00 0.00% |
Vg Life holds a performance score of 20 on a scale of zero to a hundred. The entity owns a Beta (Systematic Risk) of 0.0, which indicates not very significant fluctuations relative to the market. the returns on MARKET and Vg Life are completely uncorrelated. Use Vg Life Sciences daily balance of power , to analyze future returns on Vg Life Sciences.
Risk-Adjusted Performance
20 of 100
Weak | Strong |
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Vg Life Sciences are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile essential indicators, Vg Life unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 713.9 K |
VGLS |
Vg Life Relative Risk vs. Return Landscape
If you would invest 0.00 in Vg Life Sciences on August 31, 2024 and sell it today you would earn a total of 0.01 from holding Vg Life Sciences or generate 9.223372036854776E16% return on investment over 90 days. Vg Life Sciences is currently generating 73.0159% in daily expected returns and assumes 275.4506% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than VGLS, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Vg Life Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Vg Life's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Vg Life Sciences, and traders can use it to determine the average amount a Vg Life's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.2651
| Best Portfolio | Best Equity | VGLS | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 275.45 actual daily | 96 96% of assets are less volatile |
Expected Return
| 5.01 actual daily | 96 96% of assets have lower returns |
Risk-Adjusted Return
| 0.27 actual daily | 20 80% of assets perform better |
Based on monthly moving average Vg Life is performing at about 20% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Vg Life by adding it to a well-diversified portfolio.
Vg Life Fundamentals Growth
VGLS Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Vg Life, and Vg Life fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on VGLS Pink Sheet performance.
| Return On Asset | -1.51 | |||
| Current Valuation | 4.44 M | |||
| Shares Outstanding | 107.88 M | |||
| Price To Earning | (0.14) X | |||
| Price To Book | 32.38 X | |||
| EBITDA | (3.43 M) | |||
| Cash And Equivalents | 22.92 K | |||
| Total Debt | 3.38 M | |||
| Book Value Per Share | (0.05) X | |||
| Cash Flow From Operations | (1.91 M) | |||
| Earnings Per Share | (0.07) X | |||
| Total Asset | 1.32 M | |||
| Retained Earnings | (109.84 M) | |||
| Current Asset | 40 K | |||
| Current Liabilities | 5.46 M | |||
About Vg Life Performance
Assessing Vg Life's fundamental ratios provides investors with valuable insights into Vg Life's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Vg Life is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
VG Life Sciences Inc., a biotechnology company, researches and develops a pipeline of transformative therapies for combat cancer, infectious diseases, and autoimmune diseases caused by chronic inflammation. VG Life Sciences Inc. operates as a subsidiary of Feelux Co., Ltd. VG Life operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 1 people.Things to note about Vg Life Sciences performance evaluation
Checking the ongoing alerts about Vg Life for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Vg Life Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Vg Life Sciences is way too risky over 90 days horizon | |
| Vg Life Sciences has some characteristics of a very speculative penny stock | |
| Vg Life Sciences appears to be risky and price may revert if volatility continues | |
| Vg Life Sciences currently holds 3.38 M in liabilities. Vg Life Sciences has a current ratio of 0.01, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Vg Life until it has trouble settling it off, either with new capital or with free cash flow. So, Vg Life's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Vg Life Sciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for VGLS to invest in growth at high rates of return. When we think about Vg Life's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (6.19 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Vg Life Sciences currently holds about 22.92 K in cash with (1.91 M) of positive cash flow from operations. |
- Analyzing Vg Life's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Vg Life's stock is overvalued or undervalued compared to its peers.
- Examining Vg Life's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Vg Life's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Vg Life's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Vg Life's pink sheet. These opinions can provide insight into Vg Life's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for VGLS Pink Sheet Analysis
When running Vg Life's price analysis, check to measure Vg Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vg Life is operating at the current time. Most of Vg Life's value examination focuses on studying past and present price action to predict the probability of Vg Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vg Life's price. Additionally, you may evaluate how the addition of Vg Life to your portfolios can decrease your overall portfolio volatility.